BackAcurx Pharmaceuticals Overview

Acurx Pharmaceuticals Total Liabilities

Track Acurx Pharmaceuticals's total liabilities ($2.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$2.83M
99.89% YoYΔ $-2.59B vs prior year quarter

Peer trimmed avg / median

Loading

Acurx Pharmaceuticals Total Liabilities History

Loading

Acurx Pharmaceuticals vs. peers: Total Liabilities Comparison

Loading

Acurx Pharmaceuticals Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Acurx Pharmaceuticals (ACXP) FAQ

The latest total liabilities for ACXP is $2.8M as of June 2026. That compares with $2.6B in the prior-year period — down 99.9% year over year. Investors often review this figure alongside Acurx Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, ACXP's total liabilities moved from $2.6B to $2.8M — a 99.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Acurx Pharmaceuticals's operating scale or balance-sheet position.

A total liabilities figure of $2.8M for ACXP is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ACXP's total liabilities ($2.8M), review year-over-year change from $2.6B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Acurx Pharmaceuticals's total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.